Aurora BioScience Donates Ice Cold Gloves and Socks

Aurora BioScience Donates Ice Cold Gloves and Socks

Selfless request sees Aurora BioScience donate ice cold gloves and socks as new supportive care management for cancer patients undergoing chemotherapy Aurora BioScience, a leading and respected medical device company, recently received a generous request from a...
Notice of NSW tender announcement

Notice of NSW tender announcement

Notice of NSW tender announcement Cold chain equipment and maintenance services. Aurora Bioscience has been awarded the standing offer agreement for cold chain equipment and maintenance services by NSW Government HealthShare for New South Wales (NSW).Contract type:...
Scalp cooling in integrated model of breast cancer care

Scalp cooling in integrated model of breast cancer care

Scalp cooling in integrated model of breast cancer care OVER the past decade, we have witnessed a significant shift towards a patient-centred approach to cancer care, and nowhere is this more apparent than in the care of patients with breast cancer. An integrated...
GenesisCare selects Dignitana and Aurora BioScience

GenesisCare selects Dignitana and Aurora BioScience

GenesisCare selects Dignitana and Aurora BioScience as its preferred scalp cooling provider for its rapidly expanding Australia medical oncology centres Dignitana has been selected as the preferred scalp cooling provider by Australia-headquartered GenesisCare, one of...
MaxQ Thermal Shipping Technology

MaxQ Thermal Shipping Technology

Aurora BioScience are pleased to announce that we have secured the Australia and New Zealand rights to supply the innovative MaxQ thermal shipping technology products. MaxQ develops and manufactures some of the most innovative Blood Bank and Hospital-optimised...
DigniCap Delta Receives TGA approval

DigniCap Delta Receives TGA approval

Dignitana receives TGA approval for DigniCap Delta scalp cooling system in Australia First deliveries planned for October Dignitana AB, world leader in scalp cooling innovation, today announced that the Therapeutic Goods Administration (TGA) has cleared DigniCap...